pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 1,831 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health131
viewlistcards
  • Marketed
    alitretinoin
    Panretin (alitretinoin)
    Kaposi Sarcoma Galephar Pharmaceutical Research Inc5 cat
  • Phase 3
    bevacizumab
    Avastin (bevacizumab)
    Melanoma F. Hoffmann-La Roche Ltd5 cat
  • Marketed
    capivasertib
    Truqap (capivasertib)
    Human Epidermal Growth Factor Receptor 2 Negative Breast…$AZN ASTRAZENECA PLC5 cat
← prev
page 3 of 62
next →
Pain89
Neurology1
Marketed
epcoritamab
Epkinly (epcoritamab-bsyp)
Diffuse Large B-Cell Lymphoma
Genmab AS
5 cat
  • Marketed
    loncastuximab tesirine
    Zynlonta (loncastuximab tesirine-lpyl)
    Diffuse Large B-Cell Lymphoma$ADCT ADC Therapeutics SA5 cat
  • Marketed
    mogamulizumab
    Poteligeo (mogamulizumab)
    Peripheral T-Cell Lymphomas (PTCL) Kyowa Kirin Co Ltd5 cat
  • Marketed
    niraparib
    Zejula (niraparib)
    Metastatic Castration-Resistant Prostate Cancer (mCRPC)$JNJ JOHNSON & JOHNSON5 cat
  • Marketed
    FULVESTRANT
    FULVESTRANT
    Hormone Sensitive Breast Cancer Eagle Pharmaceuticals Inc4 cat
  • Marketed
    IFOSFAMIDE
    IFOSFAMIDE
    Germinomatous (Seminomatous) Germ Cell Tumors Baxter Healthcare Corp4 cat
  • Marketed
    OXALIPLATIN
    OXALIPLATIN
    Colon Cancer Ingenus Pharmaceuticals LLC4 cat
  • Marketed
    lutetium Lu 177 vipivotide tetraxetan
    Pluvicto (lutetium Lu 177 vipivotide tetraxetan)
    Hormone-Sensitive Prostate Cancer$NVS NOVARTIS AG4 cat
  • Marketed
    momelotinib dihydrochloride
    Ojjaara (momelotinib dihydrochloride)
    Chronic Idiopathic Myelofibrosis (Primary Myelofibrosis) GlaxoSmithKline LLC4 cat
  • Marketed
    polatuzumab vedotin
    Polivy (polatuzumab vedotin-piiq)
    Diffuse Large B-Cell Lymphoma Genentech Inc4 cat
  • Marketed
    relugolix
    Orgovyx (relugolix)
    Prostate Cancer Sumitomo Pharma America Inc4 cat
  • Marketed
    tisotumab vedotin
    Tivdak (tisotumab vedotin-tftv)
    Bladder Cancer Genmab AS4 cat
  • Marketed
    ANAGRELIDE HYDROCHLORIDE
    ANAGRELIDE HYDROCHLORIDE
    Thrombosis Takeda Pharmaceuticals USA Inc3 cat
  • Marketed
    Alimta
    Alimta (pemetrexed disodium)
    Malignant Pleural Mesothelioma Lilly USA LLC3 cat
  • Marketed
    ET-800
    HYDROCORTISONE
    Adrenal Insufficiency$ETON Eton Pharmaceuticals, Inc.3 cat
  • Marketed
    GEMCITABINE HYDROCHLORIDE
    GEMCITABINE HYDROCHLORIDE
    Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial B…$JNJ JOHNSON & JOHNSON3 cat
  • Marketed
    capecitabine
    Capecitabine
    Colon Cancer Armas Pharmaceuticals Inc3 cat
  • Marketed
    cyclophosphamide
    Cyclophosphamide (cyclophosphamide [INN])
    Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leuk… Long Grove Pharmaceuticals LLC3 cat
  • Marketed
    ensartinib hydrochloride
    Ensacove (ensartinib hydrochloride)
    Non-Small Cell Lung Cancer Xcovery Holdings Inc3 cat
  • Marketed
    futibatinib
    Lytgobi (futibatinib)
    Bile Duct Cancer (Cholangiocarcinoma) Taiho Oncology Inc3 cat
  • Marketed
    glofitamab
    Columvi (glofitamab-gxbm)
    Mantle Cell Lymphoma F. Hoffmann-La Roche Ltd3 cat
  • Marketed
    inavolisib
    Itovebi (inavolisib)
    Human Epidermal Growth Factor Receptor 2 Positive Breast… F. Hoffmann-La Roche Ltd3 cat
  • Marketed
    lazertinib mesylate
    Lazcluze (lazertinib mesylate)
    Non-Small Cell Lung Cancer$JNJ JOHNSON & JOHNSON3 cat
  • Marketed
    mosunetuzumab
    Lunsumio Velo (mosunetuzumab-axgb)
    Diffuse Large B-Cell Lymphoma Genentech Inc3 cat
  • Marketed
    quizartinib dihydrochloride
    Vanflyta (quizartinib dihydrochloride)
    Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Daiichi Sankyo Co Ltd3 cat
  • Marketed
    (abiraterone acetate + niraparib)
    Akeega ((abiraterone acetate + niraparib))
    Metastatic Castration-Resistant Prostate Cancer (mCRPC)$JNJ JOHNSON & JOHNSON2 cat
  • Marketed
    (amivantamab + hyaluronidase (human recombinant))
    Rybrevant Faspro ((amivantamab + hyaluronidase-rhu (human recombinant)))
    Recurrent Head And Neck Squamous Cell Carcinoma$JNJ JOHNSON & JOHNSON2 cat